THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 99 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.66 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $487,000 | +1523.3% | 48,092 | +1308.3% | 0.00% | – |
Q2 2022 | $30,000 | -62.5% | 3,415 | -59.4% | 0.00% | – |
Q1 2022 | $80,000 | -68.5% | 8,401 | -63.6% | 0.00% | – |
Q4 2021 | $254,000 | +2016.7% | 23,065 | +2613.5% | 0.00% | – |
Q3 2021 | $12,000 | +20.0% | 850 | +13.3% | 0.00% | – |
Q2 2021 | $10,000 | – | 750 | +4900.0% | 0.00% | – |
Q4 2020 | $0 | -100.0% | 15 | -98.6% | 0.00% | – |
Q2 2020 | $23,000 | -86.7% | 1,103 | -83.5% | 0.00% | – |
Q4 2019 | $173,000 | +76.5% | 6,689 | +32.6% | 0.00% | – |
Q3 2019 | $98,000 | +55.6% | 5,043 | +30.3% | 0.00% | – |
Q2 2019 | $63,000 | – | 3,871 | +64416.7% | 0.00% | – |
Q1 2019 | $0 | -100.0% | 6 | -96.2% | 0.00% | – |
Q4 2018 | $4,000 | +300.0% | 157 | +324.3% | 0.00% | – |
Q3 2018 | $1,000 | -93.8% | 37 | -94.8% | 0.00% | – |
Q2 2018 | $16,000 | – | 709 | +2115.6% | 0.00% | – |
Q1 2018 | $0 | -100.0% | 32 | -97.3% | 0.00% | -100.0% |
Q3 2017 | $40,000 | -71.4% | 1,177 | -66.7% | 0.00% | -66.7% |
Q2 2017 | $140,000 | +382.8% | 3,538 | +329.4% | 0.01% | +200.0% |
Q3 2016 | $29,000 | +262.5% | 824 | +129.5% | 0.00% | +100.0% |
Q2 2016 | $8,000 | – | 359 | +11866.7% | 0.00% | – |
Q1 2016 | $0 | – | 3 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madison Avenue Partners, LP | 7,269,584 | $69,497,223,000 | 12.98% |
Newtyn Management, LLC | 1,375,000 | $13,145,000 | 3.15% |
Chescapmanager LLC | 1,166,574 | $11,152,000 | 1.51% |
Baupost Group | 13,643,333 | $130,430,000 | 1.40% |
Weiss Asset Management LP | 5,412,487 | $51,743,000 | 1.07% |
CM Management, LLC | 120,000 | $1,147,000 | 0.96% |
Orbimed Advisors | 3,254,713 | $31,115,000 | 0.50% |
King Wealth Management Group | 122,000 | $1,166,000 | 0.23% |
Woodline Partners LP | 1,326,653 | $12,683,000 | 0.21% |
PDT Partners, LLC | 192,701 | $1,842,000 | 0.16% |